2020-004571-41: A Randomized, Placebo Controlled, Double Blind Study to Evaluate the Safety and Efficacy of Rabeximod Compared to Standard of Care in Patients With Moderate Coronavirus Disease (COVID-19) |
|
|
| Ongoing | 2 | 300 | Europe | Rabeximod, Capsule, hard | Cyxone AB, Cyxone AB | Coronavirus Disease (COVID-19), Coronavirus Disease (COVID-19), Diseases [C] - Respiratory Tract Diseases [C08] | | | | |
2021-006665-38: A study to evaluate the possible side and the efficacy of orally administered Rabeximod when taken in combination with methotrexate compared with Methotrexate only in patients with active, moderate to severe rheumatoid arthritis with inadequate response to methotrexate |
|
|
| Ongoing | 2 | 160 | Europe | Rabeximod, OXY-001, Capsule | Cyxone AB, Cyxone AB | Active, moderate to severe rheumatoid arthritis with inadequate response to methotrexate, Active rheumatoid arthritis which is not adequately responding to methotrexate, Diseases [C] - Musculoskeletal Diseases [C05] | | | | |